Identification and validation of a novel cuproptosis-related gene signature in multiple myelomaBingxin Zhang, Yongyong Ma, Quanqiang Wang et al.|Frontiers in Cell and Developmental Biology|2023Cited by 14
[Toxicity Management and Efficacy Evaluation of BCMA-CART in the Treatment of Relapsed and Refractory Multiple Myeloma].Xiaoyuan Zhang, Songfu Jiang, Hanyi Ding et al.|PubMed|2022Cited by 1
Leveraging a disulfidptosis-based signature to characterize heterogeneity and optimize treatment in multiple myelomaBingxin Zhang, Yongyong Ma, Dong Zheng et al.|Frontiers in Immunology|2025Cited by 1
Effect of Two Conditionings on Relapse in Myelodysplastic Syndrome and Secondary Acute Myeloid Leukemia Undergoing Allogeneic Hematopoietic Cell TransplantationLi Xuan, Qifa Liu, Xinquan Liang et al.|Blood|2022Cited by 0